RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa sold $342K of Relmada Therapeutics, Inc.
Sold$342,392
$34.24Price
10,000Shares
−10%Stake
What RLMD did after the filing
- The stock from Fri, Feb 26 close, $33.34
- +7.0%
- S&P 500, same days
- +8.6%
Measured over 30 trading days, to the Apr 12 close.
Traded Wed, Feb 24. Filed Fri, Feb 26, 11:50 AM ET, during the session. Returns use the Feb 26 close and the Apr 12 close. Not investment advice.